The Journal of Dental Sciences and Education deals with General Dentistry, Pediatric Dentistry, Restorative Dentistry, Orthodontics, Oral diagnosis and DentomaxilloFacial Radiology, Endodontics, Prosthetic Dentistry, Periodontology, Oral and Maxillofacial Surgery, Oral Implantology, Dental Education and other dentistry fields and accepts articles on these topics. Journal of Dental Science and Education publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Case Report
Management of initial and surgical management of amlodipine-induced gingival enlargement with multifactorial etiology: a case report with 6 months follow-up
Drug-induced gingival enlargement can be seen as a side effect of systemically used drugs such as calcium channel blockers, anticonvulsants, and immunosuppressants. One of these drugs is amlodipine, a dihydropyridine derivative calcium channel blocker used in the treatment of high blood pressure and coronary artery disease. Amlodipine-induced gingival overgrowth is rarely seen compared to other calcium channel blockers. The aim of this case is to present the diagnosis of gingival overgrowth due to amlodipine use and the identification of other etiologic factors such as labial frenulum, phase 1 initial, and phase 2 surgical treatment approaches. A 56-year-old female patient presented to our clinic with severe gingival overgrowth, intense bleeding, difficulty feeding, and pain. The anamnesis revealed that she had hypertension and had been taking amlodipine derivative Norvasc 10 mg once a day for 8 years. A look inside the mouth showed that there was a lot of gum tissue growing over the crowns from the labial and palatal sides, mainly in the front of the maxilla. Phase 1 treatment was initiated. As a result of the consultation with the patient's cardiologist, the hypertension medication Norvasc 10 mg was replaced with Candexil 16 mg by the medical physician. The preoperative tension and blanch test was positive, and the labial frenulum was seen to mobilize the free gingival margin of the central teeth. After the same session of gingivoplasty, the labial frenulum was removed by a frenectomy operation. After the operation, antibiotics, analgesics, and mouthwash were prescribed. The patient stated that he did not have any problems after the operation. 6-month follow-up showed uneventful healing. No recurrence of gingival growth was found in the 1st, 3rd, and 6th month follow-ups. In conclusion, this case report shows that non-surgical periodontal treatment alone isn't always enough to treat drug-induced gingival overgrowths. The gingival shape should be changed so that the patient can properly clean their teeth, and drug-induced gingival overgrowths, like the one in this case, may have more than one cause and may need additional surgery like a labial frenectomy.

1. Portnoy PS, Lee SY, Ashley McMullen A, Qu V. Amlodipine-InducedGingival Overgrowth: A Health Justice Issue. The Journal for NursePractitioners, Volume 18, Issue 1, 123-127
2. Rajaram Mohan K, Fenn SM, Pethagounder Thangavelu R,Subramaniam M. Amlodipine-Induced Gingival Hypertrophy: A CaseReport. Cureus, 2023;15(2), e35540.
3. Tomar LR, Aggarwal A. Missing diagnosis: gingival hypertrophy due toamlodipine. Indian heart journal, 2015 ;67(5), 491-492.
4. Lafzi A, Farahani RMZ, Shoja MAM. Amlodipine-induced gingivalhyperplasia. Med Oral Patol Oral Cir Bucal 2006;11: E480-2.
5. Göksu Çetinkaya AP, Asgarova L. Nadir Bir Yan Etki OlarakAmlodipine Bağlı Dişeti Hiperplazisi. Çocuk Dergisi, 2020;20(1), 33-35.doi.org/10.26650/jchild.2020.1.0006
6. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-inducedgingival overgrowth. Journal of clinical periodontology, 2000;27(4),217-223.
7. Ellis J, Seymour,R, Steele J, Robertson P, Butler T, JM T. Prevalenceof gingival overgrowth induced by calcium channel blockers: acommunity based study. Journal of Periodontology 1999;70, 63-67.
8. Bhandari S, Siwakoti S, Shrestha S, Gautam K, Bhandari S. Drug-Induced Gum Overgrowth With Low-Dose Amlodipine: A CaseReport. Cureus, 2022;14(5), e25220.
9. Dongari-Bagtzoglou A. Research, Science and Therapy Committee,American Academy of Periodontology. Drug-associated gingivalenlargement. Journal of periodontology, 2004;75(10), 1424-1431.
10. Brown RS, Arany PR. Mechanism of drug-induced gingival overgrowthrevisited: a unifying hypothesis. Oral diseases, 2015;21(1), e51-e61.
11. Tungare, S., & Paranjpe, A. G. (2022). Drug-Induced GingivalOvergrowth. In StatPearls. StatPearls Publishing.
Volume 1, Issue 4, 2023
Page : 123-126